“The new drugs for the treatment of overweight and obesity, i.e. semaglutide and tirzepatide arriving soon, are very interesting because they reduce the sense of hunger, therefore offering weight loss without the enormous efforts that the subject suffering from obesity has to undergo undergo if he does not resort to surgery. They are not drugs that are antagonistic to surgery, I would say that more than anything it is a synergy. Surgery is still today the most effective means we have for treating third degree and even second degree obesity but in first degree obesity these drugs are able to give us excellent results without necessarily having to resort to surgery of bariatric surgery”. Thus Giuseppe Maria Marinari, head of the Bariatric Surgery Operational Unit at Irccs Humanitas in Milan, on the sidelines of the 32nd National Congress of the Italian Society of Obesity Surgery (Sicob) entitled ‘Obesity: in search of a new therapeutic alliance’, scheduled from 23 to 25 May in Giardini Naxos (Messina) and which sees the presence of over a thousand specialists from all over Italy.
#Marinari #Humanitas #effective #weapon #obesity #drugs
